Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06591806 · ClinicalTrials.gov registry record
An Observational Study in Children and Adults With Stargardt Disease
A clinical trial of Stargardt Disease, sponsored by AAVantgarde Bio Srl.
- Recruiting
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT06591806 is a study of Stargardt Disease that is actively recruiting participants, run by AAVantgarde Bio Srl. The registered enrollment target is 80 participants, roughly in line with the 86-participant average among 16 other Stargardt Disease trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT06591806, a study of Stargardt Disease, is actively recruiting participants, sponsored by AAVantgarde Bio Srl.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future clinical studies.
Conditions Studied
Study Locations (2)
Texas
- Retina Foundation of the Southwest - Dallas
Other
- Oslo University hospital Ullevål - Oslo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2024-05-01 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06591806
The ClinicalTrials.gov registry entry for NCT06591806 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 86-participant average among 16 other Stargardt Disease trials with a reported enrollment target. The listed sponsor is AAVantgarde Bio Srl, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stargardt Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06591806 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Other.
Frequently Asked Questions
What is clinical trial NCT06591806 about?
NCT06591806 is a clinical study titled "An Observational Study in Children and Adults With Stargardt Disease". This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future cl...
What is the current status of trial NCT06591806?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2024-05-01. Estimated completion is 2027-06-30.
What conditions does trial NCT06591806 study?
This clinical trial studies the following conditions: Stargardt Disease.
Who is sponsoring clinical trial NCT06591806?
This trial is sponsored by AAVantgarde Bio Srl, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06591806 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stargardt Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
RECRUITING · Phase 1
-
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
RECRUITING
-
An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
RECRUITING
-
Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
RECRUITING
-
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
RECRUITING · Phase 2
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.